SHG · Healthcare

Shanghai Medicilon Inc (688202)

Biotechnology

Shanghai Medicilon Inc (688202) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $8.10B, P/E ratio is 18.00, net margin is -21.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 688202

Market cap
$8.10B
P/E ratio
18.00
Gross profit (TTM)
$143.26M
Net margin
-21.5%

Shanghai Medicilon Inc (688202) — FAQ

What is Shanghai Medicilon Inc's market cap?

Shanghai Medicilon Inc (688202) has a reported market cap of $8.10B (data as of 2026-03-29).

What is 688202's P/E ratio?

The price-to-earnings (P/E) ratio for Shanghai Medicilon Inc (688202) is 18.00 (data as of 2026-03-29).

Does Shanghai Medicilon Inc pay a dividend?

Dividend yield is not available in the current snapshot for Shanghai Medicilon Inc (688202). Check the MyAverix Finance app for the latest dividend data.

What sector is Shanghai Medicilon Inc in?

Shanghai Medicilon Inc (688202) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 688202 listed on?

688202 is listed on SHG.

What is Shanghai Medicilon Inc's net margin?

Shanghai Medicilon Inc (688202) reports a net margin of -21.5% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play